We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+26.42%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.88B
AUM Growth
+$195M
Cap. Flow
-$185M
Cap. Flow %
-9.85%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$9.78M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$125M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$69.8M

Sector Composition

Rank Sector Weight
1 Healthcare 62.62%
2 Consumer Staples 22.55%
3 Miscellaneous 9.07%
4 Industrials 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.13B
$1.01B 53.49%
9,544,091
-1,251,257
-12% -$125M
MNST icon
2
Monster Beverage
MNST
$87.7B
$424M 22.55%
18,625,952
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$77.2B
$152M 8.1%
690,000
-319,700
-32% -$69.8M
AXON
4
Axon Enterprise
AXON
$38.4B
$108M 5.75%
760,062
– –
IMDX
5
Insight Molecular Diagnostics
IMDX
$125M
$87.1M 4.63%
838,824
+103,014
+14% +$9.78M
LCTX icon
6
Lineage Cell Therapeutics
LCTX
$266M
$79.9M 4.25%
34,005,379
– –
MNST icon
7
PUT
Monster Beverage
MNST
$87.7B
$18.2M 0.97%
800,000
+400,000
+100% +$8.96M
SER icon
8
Serina Therapeutics
SER
$58.2M
$4.86M 0.26%
85,219
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Broadwood Capital held 8 positions worth $1.88B, up 12% from $1.69B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $185M in Q1 2021, reducing 2 holdings. Its largest reduction was STAAR Surgical, cutting an estimated $125M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 57% a quarter earlier, followed by Consumer Staples and Miscellaneous.

Against the trend, Broadwood Capital added an estimated $9.78M to Insight Molecular Diagnostics.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q1 2021, an estimated $9.78M increase.
  • Broadwood Capital's biggest Q1 2021 reduction was STAAR Surgical, cutting an estimated $125M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.88B portfolio in Q1 2021.
  • Broadwood Capital opened 0 new positions and closed 0 in Q1 2021.
  • Broadwood Capital's portfolio value rose 12% quarter-over-quarter to $1.88B.

Based on Broadwood Capital's 13F filing for Q1 2021, filed 17 May 2021.